Gestelmir

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameGestelmir
Drug Alias NameGSE24.2-peptide
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTelomerase activators
TargetsTelomerase
Therapy Area/IndicationsDyskeratosis Congenita
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Medical Projects
Active IndicationsN/A
Inactive IndicationsDyskeratosis Congenita

Other Information

ATC CodeN/A
Related LinksN/A